DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ...

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groups Accelerated rates ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...

Groups G and H used pure GLP-1 drugs (semaglutide and liraglutide respectively) in DehydraTECH compositions Recalculations led to slight changes from earlier reported data Lexaria is strongly ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX) has announced partial final results from its WEIGHT-A24-1 animal study, showing positive outcomes for its DehydraTECH-liraglutide and certain ...

Lexaria notes that it has already filed patent applications to recognize the unique outperformance of liraglutide once processed with DehydraTECH delivery technology. Readers are cautioned to not ...

Lexaria Bioscience Corp. (NASDAQ:LEXX), a pharmaceutical preparations company, announced today that it will hold a combined Annual and Special Meeting of Shareholders on January 14, 2025. This ...

Lexaria Bioscience Corp. (NASDAQ:LEXX), a pharmaceutical preparations company, announced today that it will hold a combined Annual and Special Meeting of Shareholders on January 14, 2025.